Patent Application
Utility
App. No. 18/814,217
· Confirmation No. 7978
SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHODS OF USE
Applicant:
Kura Oncology, Inc.
Abandoned -- Incomplete Application (Pre-examination)
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-05-13 | ABN |
Abandonment | 2 | View | |
| 2025-01-17 | XT/ |
Extension of Time | 1 | View | |
| 2025-01-17 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2025-01-17 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-09-04 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2024-09-04 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2024-09-04 | WCLM |
Claims Worksheet (PTO-2022) | 2 | View | |
| 2024-09-04 | NTC.MISS.PRT |
Notice to File Missing Parts | 3 | View | |
| 2024-09-04 | WELCOME.LET |
Welcome Letter from USPTO Director and Deputy Director | 1 | View | |
| 2024-08-26 | CRFE |
Sequence Listing in Computer Readable Format, No errors found | — | View | |
| 2024-08-26 | CRFE |
Sequence Listing in Computer Readable Format, No errors found | 5 | View | |
| 2024-08-23 | SPEC |
Specification | — | View | |
| 2024-08-23 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View | |
| 2024-08-23 | SPEC |
Specification | 167 | View | |
| 2024-08-23 | CLM |
Claims | 22 | View | |
| 2024-08-23 | ABST |
Abstract | 1 | View | |
| 2024-08-23 | OATH |
Oath or Declaration filed | 3 | View | |
| 2024-08-23 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2024-08-23 | ADS |
Application Data Sheet | 9 | View | |
| 2024-08-23 | DRW |
Drawings-only black and white line drawings | 3 | View | |
| 2024-08-23 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2024-08-23 | SEQ.XML |
Sequence Listing (XML File) | 1 | View |
Inventors
Attorneys & Agents of Record
Prosecution
- Customer No.
- 21971
- Docket No.
- 47535-729.303
- Confirmation No.
- 7978
Parent
is a Continuation of
→
App. 18/543,945
Filed 2023-12-18
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 18/185,936
Filed 2023-03-17
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 16/647,855
· US 11,649,251
Filed 2020-03-16
· Patented Case
Parent
PCT
is a National Stage Entry of
→
PCT/US2018/051666
Filed 2018-09-19
· Abandoned -- Incomplete Application (Pre-examination)
Parent
Claims priority from a provisional application
→
App. 62/637,074
Filed 2018-03-01
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 62/595,436
Filed 2017-12-06
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 62/577,644
Filed 2017-10-26
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 62/561,089
Filed 2017-09-20
· Provisional Application Expired
Child
is a Continuation of
→
App. 19/029,076
Filed 2025-01-17
· Docketed New Case - Ready for Examination
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2024-11-07
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 18/814,217
- Filed
- 2024-08-23
External Links